Trial · NCT07895030
Visual and Auditory Stimulation in Intensive Care Patients
NCT07895030, Not applicable, Not yet recruiting, University of Yalova
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Visual and Auditory Stimulation in Intensive Care Patients. Trials, record NCT07895030. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07895030
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Visual and Auditory Stimulation in Intensive Care Patients
- NCT number
- NCT07895030
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 44 participants, estimated
- Lead sponsor
- University of Yalova
- Conditions
- Dyspnea, Sleep Quality, Anxiety, Intensive Care Patients
- Interventions
- The Northern Lights and White Noise
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Effect of Northern Lights and White Noise on Dyspnea: Dyspnea-12 (D-12) | 2 month | The Dyspnea-12 is a validated instrument used to assess the severity of dyspnea. It consists of 12 items evaluating the physical and affective dimensions of breathlessness. Dyspnea will be assessed before and immediately after each 30-minute intervention session on two consecutive nights in the intervention group and at corresponding time points in the standard care group. |
| Primary | Effect of Northern Lights and White Noise on Anxiety: State Anxiety Inventory | 2 month | The State Anxiety Inventory (STAI-S) is used to assess an individual's current level of anxiety. It consists of 20 items, with higher scores indicating greater state anxiety. Anxiety will be assessed before and immediately after each 30-minute intervention session on two consecutive nights in the intervention group and at corresponding time points in the standard care group. |
| Primary | Effect of Northern Lights and White Noise on Sleep Quality: Richards-Campbell Sleep Questionnaire (RCSQ) | 2 month | The Richards-Campbell Sleep Questionnaire is a validated instrument used to assess sleep quality in intensive care patients. It evaluates perceived sleep depth, sleep latency, awakenings, return to sleep, and overall sleep quality. Sleep quality will be assessed at 08:00 AM on the morning following each study night in both groups. |
| Primary | Effect of Northern Lights and White Noise on Pulse Rate | 2 month | Pulse rate will be recorded to evaluate physiological responses to the intervention. Measurements will be obtained before and immediately after each 30-minute intervention session on two consecutive nights in the intervention group and at corresponding time points in the standard care group. |
| Primary | Effect of Northern Lights and White Noise on Blood Pressure | 2 month | Blood Pressure rate will be recorded to evaluate physiological responses to the intervention. Measurements will be obtained before and immediately after each 30-minute intervention session on two consecutive nights in the intervention group and at corresponding time points in the standard care group. |
| Secondary | Effect of Northern Lights and White Noise on Oxygen Saturation | 2 Month | Saturation will be recorded to evaluate physiological responses to the intervention. Measurements will be obtained before and immediately after each 30-minute intervention session on two consecutive nights in the intervention group and at corresponding time points in the standard care group. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07895030
GET https://conductscience.org/api/trials/v1/NCT07895030/registered